GlassScriptPrepare for your visit
Stephen Charles Sizer
Orthopaedic Surgery · Philadelphia, PA · NPI 1023377751
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$4,156.86
in general payments reported to CMS, 2019-2025 · $1,340 in 2025
The $1,340 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Who reported paying
General payments only, top 6 by amount.
- Stryker Corporation $3,066.73
- Orthalign INC $274.22
- Zimmer Biomet Holdings, INC. $139.54
- Smith+Nephew, INC. $135.66
- Abbvie INC. $120.05
- Bioventus LLC $110.76
Drugs and devices associated with these payments
Mako Orthalign Plus Exeter Trident Insignia Rinvoq Palacos Triathlon Axsos Durolane Gel-One Cross-Linked Hyaluronate Gamma
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Stephen Sizer listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/864/stephen-charles-sizer